Pharmaceuticals

What Is The Predicted Revenue Outlook For The Immunohematology Market To Surpass $3.17 Billion?

October 16, 2025 by Marketing Posting

Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

#What Are The Market Size Estimates For The Immunohematology Market?#_x000D_

In recent times, there has been consistent growth in the size of the immunohematology market. It is expected to expand from $2.46 billion in 2024 to $2.55 billion in 2025, a compound annual growth rate (CAGR) of 3.6%. The surge in the historical period can be credited to the progression in blood transfusion science, commonality of blood disorders, growth of blood banks, government-led initiatives for blood security, an increase in surgical operations, and heightened awareness regarding the dangers associated with transfusion._x000D_

_x000D_

Expectations are high for considerable expansion in the immunohematology market size in the upcoming years. The market is projected to hit “$3.17 billion in 2029” with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth during the prediction period include escalating demand for point-of-care testing, the development of new blood products, enhancement in healthcare infrastructure, blood compatibility genetic testing, and the ongoing regulatory backing for blood safety. Key trends during the projection period comprise automation, high-throughput systems, innovative blood typing methods at a molecular level, antibody spotting techniques, patient blood management initiatives, artificial intelligence integration in analysis, and telemedicine integration._x000D_

_x000D_

#Get A Free Sample Of The Report:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=10295&type=smp_x000D_

_x000D_

#What Drivers Are Accelerating Expansion Of The Immunohematology Market?#_x000D_

The escalating incidence rate of hematological disorders is anticipated to fuel the expansion of the immunohematology market in the future. Hematological disorders comprise a varied group of conditions impacting the blood and blood components such as red and white blood cells, platelets, and plasma. Immunohematology plays a crucial role in ensuring safe and successful blood transfusions by averting transfusion reactions due to incompatible blood types or the existence of antibodies in the receiver’s blood. Additionally, immunohematology methods are employed to detect and treat immune system-related disorders that could affect the hematologic system. For example, Cancer Research UK, a UK-based research institution, estimated that the number of new leukemia cases due to hematological disorders in the UK is projected to rise from nearly 12,400 cases in 2023-2025 to approximately 14,500 cases in 2038-2040. Thus, the increasing incidence rate of hematological disorders is promoting the growth of the immunohematology market._x000D_

_x000D_

#How Is The Immunohematology Market Organized By Different Segments?#_x000D_

The immunohematology market covered in this report is segmented – _x000D_

_x000D_

1) By Product: Analyzers And Systems, Reagents_x000D_

2) By Technology: Biochips, Erythrocyte-Magnetized Technology (Met), Gel Cards, Microplates, Polymerase Chain Reaction (PCR)_x000D_

3) By Disease: Blood-Related Diseases, HIV, Hepatitis_x000D_

4) By Application: Pretransfusion Testing, Investigation Of Immune Hemolysis, Perinatal Testing, Blood Group Phenotyping, Leucocyte And Platelet Serology_x000D_

5) By End User: Blood Banks, Diagnostic And Reference Laboratories, Hospitals, Academic And Research Institutes_x000D_

_x000D_

Subsegments:_x000D_

1) By Analyzers And Systems: Blood Typing Analyzers, Cross-Matching Analyzers, Gel Card Systems_x000D_

2) By Reagents: Blood Grouping Reagents, Antisera, Control Serum_x000D_

_x000D_

#What Current And Upcoming Trends Are Shaping The Immunohematology Market?#_x000D_

Leading corporations in the immunohematology market are concentrating their efforts on creating groundbreaking diagnostic solutions to counteract the interference of the cancer medication, daratumumab. These solutions often involve the use of soluble recombinant proteins, which are proteins generated through recombinant DNA technology that remain functional in soluble forms in host cells or solutions, making them ideal for research or certain therapy applications. In November of 2023, the Spain-based pharmaceutical corporation Grifols, S.A. introduced the Grifols sCD38 solution, marking the first implementation of a soluble recombinant protein. This solution was specially crafted to negate the complications induced by daratumumab in essential blood transfusion compatibility tests, particularly for those suffering from multiple myeloma. The revolutionary Grifols sCD38 solution prevents daratumumab from latching onto CD38 proteins found in red blood cells, ensuring accurate results from pre-transfusion testing. By streamlining the process for screening, identification, and crossmatching, Grifols sCD38 has improved blood transfusion procedures, reducing delays for these critical procedures._x000D_

_x000D_

#Which Firms Are Making The Biggest Impact In The Immunohematology Market?#_x000D_

Major companies operating in the immunohematology market include Ortho Clinical Diagnostics Inc., Immunocor Inc., Abbott Laboratories, Siemens Healthineers AG, Grifols S.A., Beckman Coulter Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, Merck Co. & KGaA, Bio-Rad Laboratories, Sysmex Corporation, Danaher Corporation, Biosystems S.A., Roche Holdings AG, Mindray Medical International Limited, F.Hoffmann La-Roche Ltd., Biotest AG, Cardinal Health Inc., Quotient Limited, DiaSorin S.p.A., Lorne Laboratories Ltd., Biokit S.A., Avox Technologies, Diagnostic Automation/Cortez Diagnostics Inc., Inno-train Diagnostik GmbH, Drucker Diagnostics Inc., Immundia Diagnostics Pvt. Ltd. _x000D_

_x000D_

#Access The Complete Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/immunohematology-global-market-report_x000D_

_x000D_

#Which Region Dominates The Immunohematology Market Today?#_x000D_

North America was the largest region in the immunohematology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global immunohematology market during the forecast period. The regions covered in the immunohematology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa_x000D_

_x000D_

#Customize Your Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=10295&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_